SYRS
Syros Pharmaceuticals, Inc. Common Stock
SYRS
SYRS
Delisted
SYRS was delisted on the 19th of March, 2025.
90 hedge funds and large institutions have $166M invested in Syros Pharmaceuticals, Inc. Common Stock in 2021 Q4 according to their latest regulatory filings, with 12 funds opening new positions, 31 increasing their positions, 31 reducing their positions, and 22 closing their positions.
Holders
90
Holders Change
-10
Holders Change %
-10%
% of All Funds
1.39%
Holding in Top 10
1
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.02%
New
12
Increased
31
Reduced
31
Closed
22
Calls
$85K
Puts
$249K
Net Calls
-$164K
Net Calls Change
+$1.16M
Top Buyers
Top Sellers
| 1 |
1
Marshall Wace
London,
United Kingdom
|
$0 |
| 2 |
2
Millennium Management
New York
|
$301K |
| 3 |
3
Vanguard Group
Malvern,
Pennsylvania
|
$9.1M |
| 4 |
4
Morgan Stanley
New York
|
$227K |
| 5 |
PP
5
PDT Partners
New York
|
$0 |
| Name | Holding | Trade Value |
Shares Change |
Shares Change % |
|
|---|---|---|---|---|---|
|
MLICM
101
Metropolitan Life Insurance Company (MetLife)
New York
| – | -$73.4K | -1,642 | Closed |
|
|
DTL
102
Dynamic Technology Lab
Singapore
| – | -$57K | -1,269 | Closed |
|
103
Principal Financial Group
Des Moines,
Iowa
| – | -$55K | -1,224 | Closed |
|
|
PCM
104
Penserra Capital Management
Orinda,
California
| – | -$6K | -142 | Closed |
|
|
JCM
105
Jacobi Capital Management
Pittston,
Pennsylvania
| – | -$5K | -120 | Closed |
|
|
LC
106
Lindbrook Capital
Calabasas,
California
| – | -$2K | -51 | Closed |
|
|
S
107
SignatureFD
Atlanta,
Georgia
| – | -$1K | -20 | Closed |
|
|
QCG
108
Quadrant Capital Group
Cincinnati,
Ohio
| – | -$1K | -11 | Closed |
|